作者:
Sch?ffski,P. [1]
;
Adkins,D. [2]
;
Blay,J.-Y. [3]
;
Gil,T. [4]
;
Elias,A.D. [5]
;
Rutkowski,P. [6]
;
Pennock,G.K. [7]
;
Youssoufian,H. [8]
;
Gelderblom,H. [9]
;
Willey,R. [10]
;
Grebennik,D.O.
作者单位:
University Claude Bernard Lyon, Centre Léon Bérard, Lyon, France
[1]
Centrum Onkologii-Instytut Im. Marii Sklodowskiej-Curie, Warszawa, Poland
[2]
ImClone Systems LLC, A Wholly-owned Subsidiary of Eli Lilly and Company, Bridgewater, NJ, United
[3]
Washington University, School of Medicine, St. Louis, MO, United States
[4]
University Hospitals Leuven, KU Leuven, Leuven, Belgium
[5]
Department of Clinical Oncology, Leiden University Medical Center, Leiden, Netherlands
[6]
Ziopharm Oncology, Inc., Boston, MA, United States
[7]
Institute Jules Bordet, Université Libre de Bruxelles, Belgium
[8]
Department of Medicine, University of Colorado, Aurora, CO, United States
[9]
MD Anderson Cancer Center, Orlando, FL, United States
[10]
发布时间
2014-01-21